Projects

RNDr. Mária Bartošová, PhD.

International

Finished
  • CAPSID - Scientific capacity building in biomedical research through scientific exchange and co-development of research services
    Program: European Regional Development Fund (ERDF)
    Duration: 1. 7. 2018 – 30. 6. 2021

National

Current
  • Study of inverse relationship between carbonic anhydrases CA IX and CA IV and its significance for tumor phenotype
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
Finished
  • Investigation of the Host – Parasite, Cell - Rickettsia Relationship, Monitored by Transcriptomic and Proteome Studies.
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Unraveling the mechanisms linking obesity and cancer progression: the interplay between adipocytes and cancer cells
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Clinical evaluation of prognostic and predictive value of tissue and serum Carbonic Anhydrase IX in breast cancer
    Program: Other projects
    Duration: 1. 11. 2019 – 31. 12. 2022
  • Interaction of hypoxia with the signaling pathways implicated in differentiation, tumor progression and metastasis.
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2019
  • Drug repurposing as a novel approach to therapy of colorectal carcinoma: molecular mechanisms and potential applications
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2019
  • Biochips and biosensors for glycorecognition, their development, prepararion and application in cancer research
    Program: SRDA
    Duration: 1. 7. 2015 – 30. 6. 2019
  • Preparation of erythropoietin a therapeutic hormone affecting the production of red blood cells by expression in eukaryotic cell system and its further purification
    Program: SRDA
    Duration: 1. 7. 2015 – 30. 6. 2019
  • Carbonic anhydrase IX as a functional component of cancer progression: the role in epithelial-mesenchymal transition and intercellular signaling
    Program: SRDA
    Duration: 1. 7. 2012 – 31. 12. 2015
  • Regulation of carbonic anhydrase IX release and biological role of shed ectodomain in tumor cell-cell interactions
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2015
  • Study of molecular mechanisms of carbonic anhydrase IX regulation and significance of its expression in colorectal cancer.
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2015
  • Proteomic analysis of cells with modulated expression of calcium-binding protein S100P
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2014
  • Identification of the molecular pathways driven by hypoxia-induced carbonic anhydrase IX in tumor cells
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 10. 2014
  • Biological properties and immunotherapeutic potential of the monoclonal antibodies specific for the tumor-associated protein CA IX
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2011
  • Significance of the carbonic anhydrase IX as a non-invasive prognostic indicator and a molecular target in renal cell carcinoma
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2011
Employees